1/16/19: Through Terumo's most advanced product design to date, the new Capiox NX19 oxygenator helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, minimizing inflammatory response, and providing highly efficient gaseous microemboli removal.
1/16/19: Bolder Surgical, today announced it has secured $27 million in financing led by River Cities Capital Funds with participation from Westwood Management, Providence Ventures and previous investors. The company also announced a name change to Bolder Surgical as part of a re-branding initiative to better align the company with its long-term vision of a robust product portfolio that expands beyond pediatric care.
1/16/19: The STALIF L FLX Lateral Lumbar Integrated Interbody System represents the fourth system of 3D-Printed All-Titanium devices to be launched by Centinel Spine within the last 6 months, in addition to the STALIF C FLX™ Cervical Integrated Interbody, ACTILIF C FLX™ Cervical Interbody, and STALIF M FLX™ Lumbar Integrated Interbody devices.
1/16/19: “Data clearly show that both men and women have significant misconceptions about men’s health, including BPH and the ways to treat the condition,” said Ana Fadich, vice president of Men’s Health Network.
1/16/19: The Chocolate Touch® US pivotal study is a prospective randomized study in the US, Europe, and New Zealand that will evaluate patients with disease in the superficial femoral and popliteal arteries in the legs.
1/14/18: The company will use the proceeds to expand their worldwide commercialization efforts for mi-eye 2™ and mi-ultra™ and to accelerate the development of their minimally invasive product portfolio.